Xin Li
- Molecular Biology top 1%
- Cancer Research top 0.2%
- Oncology top 1%
- Immunology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Topics
- Cancer-related molecular mechanisms research (63 papers)RNA modifications and cancer (51 papers)MicroRNA in disease regulation (44 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xin Li
374 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Molecular Biology 5.5k
- Cancer Research 3.4k
- Oncology 1.9k
- Immunology 1.2k
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Xin Li
This map shows the geographic impact of Xin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Li more than expected).
Fields of papers citing papers by Xin Li
This network shows the impact of papers produced by Xin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Li. The network helps show where Xin Li may publish in the future.
Co-authorship network of co-authors of Xin Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xin Li. A scholar is included among the top collaborators of Xin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Li. Xin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 12 | |
| 11 | 6 | |
| 12 | 7 | |
| 13 | 10 | |
| 14 | 3 | |
| 15 | 16 | |
| 16 | 7 | |
| 17 | 8 | |
| 18 | 117 | |
| 19 | 88 | |
| 20 | 122 |
About Xin Li
Xin Li is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 390 papers that have together received 9.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (63 papers), RNA modifications and cancer (51 papers) and MicroRNA in disease regulation (44 papers). The work is most often cited by research in Cancer Research (3.4k citations), Molecular Biology (5.5k citations) and Oncology (1.9k citations). Xin Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hua Tang, Min Liu, Haiying Wan, Tao Liu, Weiyi Fang, Min Liu, Xiaoming Lyu, Kai‐Tai Yao, Min Liu and Huiling Yang. Their work appears in journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.